Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.18 (8.955%)
Market Cap: £44.34m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

EGM Statement

23 Jul 2012 14:27

RNS Number : 2828I
Quintain Estates & Development PLC
23 July 2012
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

23 July 2012

Quintain Estates and Development plc ("Quintain")

New joint venture with Hong Kong investor to develop Greenwich Peninsula

Result of General Meeting

Further to the announcements on 18 June 2012 and 4 July 2012, Quintain announces that, at the general meeting held today, the resolution to approve the new joint venture relating to Greenwich Peninsula Regeneration Limited with Knight Dragon Limited, an investment vehicle ultimately owned by Dr. Henry Cheng Kar-Shun, was passed by shareholders. Completion of the transaction is scheduled to take place on Friday 27 July 2012.

The results of the vote (conducted by way of a poll) are shown below.

Votes For

392,935,646

Votes Against

9,064

Votes Withheld

1,807,129

Total votes

394,751,839

 

ENQUIRIES:

Quintain Estates and Development plc

Maxwell James, Chief Executive Tel: +44 (0) 20 7495 8968

Rebecca Worthington, Deputy Chief Executive

 

HSBC Bank Plc, Sole Financial Adviser to Quintain and Sole Sponsor

Richard Choi Tel: +44 (0) 20 7991 8888

Oliver Smith

 

RLM Finsbury

James Bradley Tel: +44 (0) 20 7251 3801

Jenny Davey 

 

Barclays Bank PLC, Joint Corporate Broker to Quintain

Tom Boardman Tel: +44 (0) 20 7623 2323

 

J.P. Morgan Cazenove, Joint Corporate Broker to Quintain

Robert Fowlds Tel: +44 (0) 20 7742 4000

Bronson Albery

 

 

Important Notices

The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom should inform themselves about, and observe, any applicable requirements. This announcement has been prepared for the purposes of complying with the Listing Rules and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of England.

HSBC Bank Plc, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as sole financial adviser and sole sponsor for Quintain and no-one else in connection with the Transaction and the contents of this announcement and will not be responsible to anyone other than Quintain for providing the protections afforded to clients of HSBC Bank Plc, or for providing advice in relation to any of the Transaction, the contents of this announcement or any matters referred to herein.

Barclays Bank PLC, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as joint corporate broker to Quintain and no-one else in connection with the Transaction and the contents of this announcement and will not be responsible to anyone other than Quintain for providing the protections afforded to clients of Barclays Bank PLC, or for providing advice in relation to any of the Transaction, the contents of this announcement or any matters referred to herein.

J.P. Morgan Cazenove, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as joint corporate broker to Quintain and no-one else in connection with the Transaction and the contents of this announcement and will not be responsible to anyone other than Quintain for providing the protections afforded to clients of J.P. Morgan Cazenove, or for providing advice in relation to any of the Transaction, the contents of this announcement or any matters referred to herein.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMEADXDAADAEFF
Date   Source Headline
1st Aug 20247:00 amRNSValkor Project Update
10th Jul 20247:00 amRNSMarine Project Update
26th Jun 20247:00 amRNSExtended agreement with BTG Bioliquids for bioMSAR
29th May 20247:00 amRNSRepresentation Agreement Addendum & Warrants Grant
28th May 20247:00 amRNSOCP Commercial Framework Agreement
2nd May 20247:00 amRNSQuadrise-Vertoro JDA to sea-trial bioMSAR Zero
29th Apr 20247:00 amRNSMarine Project Update
19th Apr 20247:00 amRNSValkor Project Update
12th Apr 20244:58 pmRNSResults of Open Offer
22nd Mar 20243:10 pmRNSExtension of Open Offer Closing Date
20th Mar 20241:01 pmRNSInvestor Presentation
19th Mar 20247:00 amRNSPlacing Results, Open Offer & Posting of Circular
18th Mar 20244:55 pmRNSProposed Placing, Subscription and Open Offer
18th Mar 20244:53 pmRNSInterim Results
15th Feb 20247:00 amRNSAgreement with Euthenia & BTG Bioliquids
6th Feb 20247:00 amRNSMarine Project Update
6th Dec 20237:00 amRNSUpdate re bioMSARâ„¢ and bioMSARâ„¢ Zero Development
27th Nov 20235:46 pmRNSResult of AGM
27th Nov 20237:00 amRNSAGM Statement
22nd Nov 20237:00 amRNSMorocco Project Update
9th Nov 20237:00 amRNSPublication of 2023 Sustainability Report
31st Oct 202312:45 pmRNSMorocco Project Update
27th Oct 20234:20 pmRNSPosting of Annual Report & Notice of AGM
24th Oct 20239:33 amRNSChange of Nominated Adviser
2nd Oct 20237:30 amRNSDirectorate Change
2nd Oct 20237:00 amRNSFinal Results and Notice of AGM
12th Sep 20237:00 amRNSMorocco Project Update
29th Aug 20237:00 amRNSValkor Project Update
24th Aug 202312:29 pmRNSValkor Update
18th Aug 20233:46 pmRNSMorocco Update
4th Aug 20237:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 20234:15 pmRNSDirector/PDMR Shareholding
28th Jul 20234:25 pmRNSDirector/PDMR Shareholding
25th Jul 20233:34 pmRNSResults of Open Offer
7th Jul 202312:00 pmRNSInvestor Presentation
7th Jul 202310:38 amRNSPlacing Results, Open Offer & Posting of Circular
7th Jul 20237:00 amRNSProposed Placing and Open Offer
22nd Jun 20237:00 amRNSMorocco Update
12th Jun 20237:00 amRNSValkor Site License & Supply Agreement
8th Jun 20237:00 amRNSJoint Development Agreement with BTG Bioliquids
26th May 20237:00 amRNSVertoro Joint Development Agreement Update
22nd May 20237:00 amRNSMorocco Update
16th May 20234:29 pmRNSReplacement: Business Update
16th May 20237:00 amRNSBusiness Update
25th Apr 20237:00 amRNSAppointment of Joint Broker
29th Mar 20237:00 amRNSInterim Results
28th Mar 20237:00 amRNSChange of Company Name
22nd Oct 20155:26 pmRNSDelisting of Quintain ordinary shares
15th Oct 20154:30 pmRNSHolding(s) in Company
15th Oct 20154:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.